the myotonias and hyperkalaemic periodic paralysis, which are sodium and chloride channel disorders. For about 20 known mutations in SCN4A, a gain of function mechanism causes hyper-or hypoexcitability in the sodium channel diseases through a defect in channel inactivation resulting in an increase in the sodium inward current, which depolarizes the sarcolemma. A small depolarization will increase whereas a large depolarization will decrease excitability. The same pathophysiological mechanism applies to one form of the long-QT syndrome (LQT type 3, mutations in SCN5A), an inherited cardiac arrhythmia (reviewed by Lehmann-Horn & Jurkat-Rott, 1999) .
Three forms of idiopathic epilepsies have been identified as arising from ion channel disorders. Autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE) is caused by point mutations in the a 4 -subunit of a neuronal nicotinic ACh receptor (Steinlein et al. 1995) , benign familial neonatal convulsions (BFNC) are caused by mutations in two voltage-gated potassium channels (Biervert et al. 1998; Charlier et al. 1998; Singh et al. 1998) and generalized epilepsy with febrile seizures plus (GEFS + ) is a sodium channel disorder (Wallace et al. 1998; Escayg et al. 2000) . GEFS + is a benign childhood-onset epileptic syndrome featuring different forms of febrile and afebrile seizures (Scheffer & Berkovic, 1997; Singh et al. 1999) . Five large families with autosomal dominant inheritance of GEFS + have been described so far, showing linkage to chromosome 19q13 in one case (GEFS + type 1; Wallace et al. 1998) and to chromosome 2q21-33 in the other four (GEFS + type 2; Baulac et al. 1999; Moulard et al. 1999; Pfeiffer et al. 1999; Lopez-Cendes et al. 2000) . For the chromosome 19-linked GEFS + family, a mutation has been found in SCN1B predicting substitution of tryptophan for one of two cysteine residues (C121W) that stabilize the secondary structure of the functionally important extracellular loop of the b 1 -subunit. Although this auxiliary subunit is also expressed in skeletal muscle, only epileptic seizures but no myotonia were reported for affected individuals. Functional studies in Xenopus oocytes revealed a loss of b 1 -subunit function, resulting in a decreased rate of inactivation, which increased the sodium inward current (Wallace et al. 1999 ).
The neuronal sodium channel a-subunit genes SCN1-3A are located at the GEFS + locus on chromosome 2q21-33. Recently, two mutations have been identified in SCN1A in two of the linked families (Escayg et al. 2000) . Both mutations are located in functionally important regions, the S4 voltage sensors in domains II and IV (T875M in II/S4 and R1648H in IV/S4). The voltage sensor IV/S4 has been shown previously to be important for channel inactivation and mutations therein cause paramyotonia congenita, one of the sodium channel disorders in skeletal muscle (Chahine et al. 1994; Lerche et al. 1996; LehmannHorn & Jurkat-Rott, 1999) . The sodium channel asubunits expressed in skeletal muscle and brain are highly conserved in the functionally important regions of the channel proteins and their kinetic behaviour, known from various functional studies of the human and rat isoforms, is very similar (Goldin, 1999) , but the human SCN1A gene has not been cloned and functionally expressed so far. The kinetic behaviour of the rat brain type I sodium channel (encoded by the rat SCN1A gene) has been described recently (Smith & Goldin, 1998) .
In order to study the functional consequences of a mutation causing epilepsy and also to compare the defects to mutations found in the myotonias, we introduced the SCN1A mutation R1648H in the voltage sensor IV/S4 into the same conserved region of SCN4A (R1460H) and expressed wild-type (WT) and mutant a-subunits in tsA201 cells. As expected, the gain of function was much smaller than that found for the myotonia-causing mutations located within the same channel region.
METHODS

Mutagenesis and transfection
Site-directed mutagenesis to introduce the mutation R1460H was performed using a PCR-based strategy. The mutants were reassembled in the pRC/CMV plasmid (Invitrogen) for transfection into the mammalian cell line tsA201 using a standard calcium phosphate transfection method. A CD8 cDNA-containing plasmid was cotransfected in order to allow identification of transfected cells using anti-CD8 antibody-coated microbeads (Dynabeads M450, Dynal; Lerche et al. 1997) .
Electrophysiology and data analysis
Standard whole-cell recording was performed using an EPC-7 amplifier (EPC7, List). The pipette solution contained (mM): 105 CsF, 35 NaCl, 10 EGTA and 10 Hepes (pH 7.4). The bath solution contained (mM): 150 NaCl, 2 KCl, 1.5 CaCl 2 , 1 MgCl 2 and 10 Hepes (pH 7.4). For some experiments, solutions with internal CsCl instead of CsF were used (Lerche et al. 1997) . Sodium currents in transfected cells for WT and mutant channels ranged between 2.5 and 15 nA. The maximal voltage error due to residual series resistance was < 5 mV. Leakage and capacitative currents were automatically subtracted using a prepulse protocol (_P/4). Currents were filtered at 3 or 10 kHz and digitized at 20 or 50 kHz using pCLAMP software (Axon Instruments). Measurements were performed at room temperature (21-23°C). For some experiments, the temperature was adjusted to 14.5-15.5°C via a water bath. All data were analysed using a combination of pCLAMP, Excel (Microsoft) and ORIGIN software (MicroCal). For statistical evaluation, Student's t test was applied. All data are shown as means ± S.E.M.
RESULTS
The mutation R1460H in the skeletal muscle sodium channel a-subunit predicts the substitution of histidine for the fifth of eight positively charged amino acids in the S4 voltage sensor of domain IV (IV/S4). The almost complete conservation of IV/S4 and R1460 among the SCN1A and SCN4A gene products and other known voltage-gated sodium channel a-subunits is shown in Fig. 1A . The R1460H mutation was engineered into the cDNA of the SCN4A gene, and WT or mutant plasmids were transfected into tsA201 cells. Families of normalized whole-cell sodium currents for WT and mutant channels elicited by various depolarizing voltage steps from a holding potential of _140 mV are shown in Fig. 1B . In order to look for differences in gating between WT and R1460H channels that may explain the occurrence of epileptic seizures, the kinetics and voltage dependence of activation, deactivation, fast and slow inactivation were determined.
Fast inactivation
The time course of fast inactivation was fitted to a second order exponential function. The fast time constant, r h , accounted for > 95% of the current amplitude for both WT and R1460H. There was a small but significant slowing of fast inactivation at depolarized potentials and a marked decrease in its voltage dependence in the R1460H mutant ( Fig. 2A) . The loss of voltage dependence has already been described for other mutations in IV/S4
and may indicate an uncoupling of inactivation from activation (Chahine et al. 1994; Lerche et al. 1996; Mitrovic et al. 1999) . The most distinct difference between WT and R1460H channels was found in the recovery from inactivation, measured at _100, _120 and A Na + channel mutation in human epilepsy ; n = 8, 14; P < 0.001. B, recovery from inactivation at _100 mV. Lines are fits to a first order exponential function with recovery time constants (r rec ) of 13.7 ± 1.9 vs. 4.4 ± 0.3 ms; n = 7, 11; P < 0.001; and an initial delay of 1.0 ± 0.1 vs. 0.59 ± 0.04 ms, P < 0.001, for WT and R1460H, respectively. The inset shows the voltage dependence of r rec , n = 4-11. C, steady-state inactivation was determined using 300 ms prepulses to the potentials indicated, followed by a short test pulse to _20 mV. Lines are fits to a standard Boltzmann function:
, where V 0.5 is the voltage of half-maximal inactivation and k V is a slope factor. V 0.5 was _89.0 ± 1.4 vs. _96.0 ± 1.6 mV; n = 7, 16; P < 0.02; k V was 5.5 ± 0.3 vs. 7.2 ± 0.2 mV, P < 0.001, for WT and R1460H, respectively. _140 mV after a 100 ms depolarization to 0 mV. Its time course was well fitted to a first order exponential function, yielding the time constant for recovery, r rec . For R1460H, r rec was decreased by about 3-fold at _100 mV (Fig. 2B) . The steady-state fast inactivation was shifted slightly towards more hyperpolarized potentials (Fig. 2C ).
Both the slowing of fast inactivation and the acceleration of its recovery increased excitability, as has previously been shown for SCN4A mutations causing myotonia. However, the most important finding with SCN4A mutations causing disease in skeletal muscle was an increase in the persistent sodium current depolarizing the muscle fibre membrane (Cannon, 1997; Lehmann-Horn & Jurkat-Rott, 1999) . As can be seen in Fig. 1B , there was no increase in persistent current for R1460H compared to WT channels. We determined the persistent sodium current (I ss ) at the end of a 70 ms depolarizing test pulse to _20 mV relative to the peak current (I peak ) using both a CsF and a CsCl intracellular solution (the latter was used previously to analyse myotonia-causing mutations, e.g. Mitrovic et al. 1999) . There was no significant difference between WT and R1460H channels in either solution (I ss /I peak at _20 mV for WT vs. R1460H in CsF: 0.6 ± 0.2 vs. 0.7 ± 0.3%; n = 7, 16; in CsCl: 0.7 ± 0.1 vs. 0.6 ± 0.4%; n = 7, 3).
Activation and deactivation
For a better time resolution, the kinetics of activation and deactivation were determined at 15°C. For quantification of the activation time course, the 10-90% rise time was calculated. There was a significant acceleration of the activation time course for R1460H channels between _52.5 and _30 mV (Fig. 3A) . In contrast, the deactivation time course was almost identical for the two clones (Fig. 3B ). For the steady-state activation curve we found a significant difference in slope (Fig. 3C ).
Slow inactivation
Entry into, recovery from and steady-state slow inactivation were determined as shown in Fig. 4 . Slow inactivation was slightly stabilized for R1460H channels, as revealed by a hyperpolarizing shift in steady-state slow inactivation, a more complete slow inactivation and a decreased rate of its recovery.
Effects of pH on R1460H
Protonation of the substituted histidine residue in R1460H is pH dependent. For another arginine to histidine mutation in IV/S4 causing paramyotonia congenita (R1448H), protonation at low pH restores normal gating (Chahine et al. 1994) . Since residue 1460 is only accessible from the intracellular side of the membrane (Yang et al. 1996) , we examined the gating of R1460H at intracellular pH 6.2 and 8.5. There were no significant differences in comparison to pH 7.4 in all the parameters presented in Figs 2-4 . Hence, the functional alterations of R1460H are caused by steric effects of the histidine side chain rather than by the decrease in charge.
DISCUSSION
Subtle differences in activation and fast inactivation of the voltage-gated sodium channel were identified for a mutation causing a benign form of human epilepsy.
Figure 3. Activation and deactivation parameters
A, 10-90% rise time of the sodium current as a function of test potential. The differences between mutant and WT channels over the range _52.5 to _30 mV are statistically significant at P < 0.05; n = 7, 8; T = 15°C. B, in order to measure deactivation, a short depolarizing pulse (0.5 to _10 mV) was followed by the test pulse to the indicated potentials. The deactivation time constant, r deact , was obtained from a first order exponential fit to the tail currents; n = 4, P > 0.05, T = 15°C. C, voltage dependence of activation for WT and mutant sodium channels, obtained by 25 ms depolarizing pulses to the indicated potentials from a holding potential of _140 mV. Lines are fits to a standard Boltzmann function:
). V 0.5 was _45.3 ± 1.9 vs. _44.4 ± 2.1 mV; n = 7, 6; P > 0.05; k V was 6.2 ± 0.3 vs. 7.8 ± 0.2 mV, P < 0.01, for WT and R1460H, respectively; T = 22°C.
According to the genetic data (Escayg et al. 2000) , there is no doubt that this mutation in SCN1A is causative for the disease since it cosegregates perfectly with the phenotype and is localized in an important functional region of a gene that is essential for excitability in nervous tissue. Here, we demonstrate that this mutation has functional consequences that can account for the occurrence of hyperexcitability. One might argue that we did not use the right gene for our functional studies. However, there are three important arguments that prompted us to perform the studies with the same mutation in SCN4A. First, all functionally important regions of SCN1A and SCN4A are highly conserved, as is the voltage sensor IV/S4 (Fig. 1) . Second, known functional studies of neuronal and skeletal muscle channels only showed small differences in gating (Goldin, 1999) . Third, and most important for us, the use of an established expression system, SCN4A and tsA201 cells, had the advantage that we could directly compare our results to those of previous studies concerning sodium channelopathies of skeletal muscle from our and other laboratories, in particular to those for mutations also located in IV/S4 (Chahine et al. 1994; Lerche et al. 1996; Cannon, 1997; Mitrovic et al. 1999; Lehmann-Horn & Jurkat-Rott, 1999) . Nevertheless, the data presented here must be interpreted with some caution until they have been confirmed in the human SCN1A gene in studies including coexpression of the b 1 -and b 2 -subunits, which have considerable effects on inactivation of the brain sodium channels (Smith & Goldin, 1998 ; see also the discussion about different expression systems and the b-subunit below).
The effects of R1460H on fast inactivation presented here are very small compared to those described for other mutations in SCN4A or SCN5A causing disease in skeletal or heart muscle (Cannon, 1997; Lehmann-Horn & JurkatRott, 1999) . For example, the inactivation time constant was found to be increased 3-to 6-fold for other mutations in IV/S4 causing paramyotonia congenita (R1448H/C/P: Chahine et al. 1994; Mitrovic et al. 1999) . Here, r h was increased only 1.5-fold. Moreover, the most important and the most consistent finding for almost all known mutations in SCN4A and SCN5A is an increased persistent sodium current leading to a permanent sodium inward current, which depolarizes the cell membrane. This will decrease the threshold to elicit an action potential and therefore cause hyperexcitability. A very large persistent current in combination with a defect in slow inactivation will cause an even larger depolarization that will inactivate the sodium channels and therefore result in paralysis (Cannon, 1997) . For R1460H in contrast, there was definitely no increase in persistent sodium current.
The main mechanism of the R1460H mutation causing hyperexcitability may be a combination of the faster activation time course and the 3-fold acceleration of recovery from inactivation. This will shorten both the period of depolarization needed to elicit an action potential and the refractory period after an action A Na + channel mutation in human epilepsy J. Physiol 529.3
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Figure 4. Parameters of slow inactivation
A, entry into slow inactivation at 0 mV. Cells were held at _100 mV, depolarized to 0 mV for increasing durations as indicated on the abscissa, repolarized for 100 ms to _100 mV to let the channels recover from fast inactivation and then depolarized again to _10 mV to determine the fraction of slow inactivated channels. The lines represent fits to a first order exponential function with the following time constants: 1.9 ± 0.3 for WT vs. 2.2 ± 0.1 s for R1460H; n = 3, 6; P > 0.05. B, recovery from slow inactivation measured at _100 mV after a 30 s conditioning pulse to 0 mV. Curves were best fitted to a second order exponential function with the following slow recovery time constants: r srec1 = 0.31 ± 0.11 vs. 0.46 ± 0.06 s, r srec2 = 4.2 ± 1.8 vs. 7.5 ± 1.3 s; relative amplitude of r srec1 = 54 ± 1 vs. 56 ± 4%; n = 3, 5; P > 0.05, for WT and R1460H, respectively. C, steady-state slow inactivation was determined using 30 s prepulses to potentials indicated on the abscissa, followed by a 20 ms repolarizing pulse to the holding potential of _140 mV to let the channels recover from fast inactivation, and a short test pulse to _20 mV. The data were fitted to a standard Boltzmann function: V 0.5 = _73.0 ± 1.1 for WT vs. _80.9 ± 2.1 mV for R1460H, n = 4, P < 0.02.
potential. In contrast to a persistent sodium current, neither mechanism should influence the resting membrane potential, which probably would be fatal when occurring in neurons in contrast to skeletal or heart muscle fibres. An acceleration of sodium channel activation has not been described as a disease-causing mechanism so far.
The subtle alterations in channel gating found in this study for the R1460H mutation are in line with two previous findings concerning sodium channel gating and epilepsy. First, the b 1 -subunit mutation described by Wallace and colleagues (Wallace et al. 1998 ) also shows a small defect in inactivation and causes epilepsy but no myotonia, although SCN1B is also expressed in skeletal muscle. Second, a transgenic model introducing a SCN2A mutation in the mouse yields severe status epilepticus, although the inactivation defect was also very small compared to other known mutations (Kearny et al. 1998) .
The corresponding mutation to R1460H has already been studied in the rat brain IIa sodium channel for other purposes, before it was known that this mutation can cause epilepsy (R1638H; Kühn & Greeff, 1999) . The results are difficult to compare to those presented here, since in the other study the a-subunit was expressed alone in Xenopus oocytes. Isolated expression of brain or skeletal muscle sodium channel a-subunits in oocytes results in a large decrease in the rate of inactivation. This is due to the occurrence of a second slow gating mode of inactivation that is not seen upon coexpression of the b 1 -subunit. In contrast, isolated expression of a-subunits in HEK293 or tsA201 cells does not significantly alter channel kinetics. The difference between the two expression systems is probably due to an endogenous b 1 -subunit in HEK cells (Moran et al. 2000) . The slow gating mode observed in oocytes seemed to be favoured by R1638H, resulting in a slowing of the inactivation time course.
From a biophysical point of view, our results confirm the importance of the voltage sensor in domain IV for fast channel inactivation (Chahine et al. 1994; Chen et al. 1996; Yang et al. 1996; Lerche et al. 1996; Mitrovic et al. 1999; Kühn & Greeff, 1999; Cha et al. 1999; Horn et al. 2000) . The effects on activation have not been described so far for other mutations in IV/S4 and suggest a definite role of IV/S4 in channel activation. However, the faster inactivation time course at these potentials may also influence the current rise time. The stabilization of slow inactivation observed for R1460H channels confirms an important role of IV/S4 in slow inactivation and extends recent results of Mitrovic et al. (2000) . The authors proposed a model in which mutations near the midpoint on one side of the putative IV/S4 a-helix enhance slow inactivation. R1460 is located on the same side of the helix just below the important region between residues A1453 and V1458.
We expect that more mutations in different sodium channel genes associated with epilepsy will be found in the future. It will be interesting to study these defects in comparison with disease-causing mutations in other sodium channel genes. This might establish the view presented here that such subtle alterations in gating are sufficient to cause hyperexcitability in the brain, whereas larger defects are needed to cause disease in skeletal or heart muscle.
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